EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY-NC-ND 4.0

Risk of recurrent Plasmodium vivax malaria after chloroquine plus low-dose primaquine in Pakistan: a prospective cohort study

Kamala Thriemer, Najia Ghanchi, Bushra Qurashi, Zainab Rafeeq Adam, Shane Zehra, Fareeha Abdul Jabbar, Amna Ibrahim, Nasreen Syed, Khuda Dost, Umair Ali, Tariq Mehmood, Ali Raza und 15 weitere

The Lancet Regional Health - Eastern Mediterranean · 2026

DOI: 10.1016/j.laneme.2026.100003 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift The Lancet Regional Health - Eastern Mediterranean, 2026. Verfasst von Kamala Thriemer und 26 weiteren Autor:innen. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Gates Foundation.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Plasmodium vivax remains a major public health challenge in Pakistan. Radical cure is required to eliminate liver stages of the parasite and prevent relapses, however there is limited evidence to inform the optimal primaquine regimen in Pakistan. Clinical outcomes following treatment with the national standard regimen of chloroquine and primaquine were evaluated in a prospective cohort of patients with P. vivax malaria recruited into a biobanking study.

Methods

Data from a prospective clinical cohort study in Thatta district, Sindh Province, Pakistan, were analysed to evaluate treatment outcomes. Adult patients with microscopy-confirmed P. vivax mono-infection and glucose-6-phosphate dehydrogenase (G6PD) activity ≥70% of the adjusted male median were treated, according to national guidelines, with chloroquine (25 mg/kg over 3 days) plus primaquine (0.25 mg/kg/day for 14 days; total dose 3.5 mg/kg). Treatment was provided with adherence support through phone calls and participants were followed for nine months. The cumulative risk of recurrent P. vivax parasitaemia at 9-months post treatment was estimated using Kaplan–Meier analysis. Safety outcomes included assessment of symptoms on day 14 and changes in haemoglobin concentrations during follow-up.

Findings

Between August 2023 and April 2024, 80 participants were enrolled, three of whom had P. symptomatic vivax recurrences on days 61, 158 and 189 after treatment. No asymptomatic recurrences were detected. The cumulative incidence of recurrence at 9 months was 3.9% (95% confidence interval 1.3–11.6). Treatment was well tolerated, with no serious adverse events. None of the patients had clinically significant haemolysis and haematological recovery following acute malaria was rapid.

Interpretation

In G6PD-normal adults with P. vivax malaria in southern Pakistan, there is a low risk of P. vivax recurrence within 9 months following 14-day low-dose primaquine. Funding This work was supported by the Gates Foundation.

Förderung

  • Gates Foundation

Zitieren

APA

Thriemer, K., Ghanchi, N., Qurashi, B., Adam, Z. R., Zehra, S., Jabbar, F. A., Ibrahim, A., Syed, N., Dost, K., Ali, U., Mehmood, T., Raza, A., Mnjala, H., Lee, G., Ley, B., Rai, A., Healer, J., Shah, M. A., Dhari, S., …, & Beg, M. A. (2026). Risk of recurrent Plasmodium vivax malaria after chloroquine plus low-dose primaquine in Pakistan: a prospective cohort study. The Lancet Regional Health - Eastern Mediterranean. https://doi.org/10.1016/j.laneme.2026.100003

Vancouver

Thriemer K, Ghanchi N, Qurashi B, Adam ZR, Zehra S, Jabbar FA, et al. Risk of recurrent Plasmodium vivax malaria after chloroquine plus low-dose primaquine in Pakistan: a prospective cohort study. The Lancet Regional Health - Eastern Mediterranean. 2026. doi:10.1016/j.laneme.2026.100003

BibTeX
@article{Thriemer2026,
  author = {Thriemer, Kamala and Ghanchi, Najia and Qurashi, Bushra and Adam, Zainab Rafeeq and Zehra, Shane and Jabbar, Fareeha Abdul and Ibrahim, Amna and Syed, Nasreen and Dost, Khuda and Ali, Umair and Mehmood, Tariq and Raza, Ali and Mnjala, Hellen and Lee, Grant and Ley, Benedikt and Rai, Anjana and Healer, Julie and Shah, Mushtaque Ahmed and Dhari, Sajida and Khaskheli, Abdul Hameed and Commons, Robert J and Auburn, Sarah and Sutanto, Edwin and Longley, Rhea and Price, Ric N and Mueller, Ivo and Beg, M Asim},
  title = {Risk of recurrent Plasmodium vivax malaria after chloroquine plus low-dose primaquine in Pakistan: a prospective cohort study},
  journal = {The Lancet Regional Health - Eastern Mediterranean},
  year = {2026},
  doi = {10.1016/j.laneme.2026.100003}
}
Kostenlos starten →